BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional Information (Details)	3 Months Ended						9 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2023 USD ($) customer segment	Jun. 30, 2022 USD ($) customer	Sep. 30, 2022 USD ($) customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Accumulated deficit	$ 298,854,883						$ 298,854,883		$ 292,500,088
Net loss	3,114,195	$ (551,176)	$ 3,844,246	$ 1,124,796	$ 1,759,797	$ 4,720,911	6,407,265	$ 7,605,505
Operating cash flow							3,537,911
Excess of FDIC insurance limit	8,500,000						$ 8,500,000
Number of reportable segments | segment							3
Transfers from Level 2 to Level 1, Assets	0						$ 0
Transfers from Level 1 to Level 2, Assets	0						0
Transfers from Level 2 to Level 1, Liabilities	0						0
Transfers from Level 1 to Level 2, Liabilities	$ 0						0
Transfers Into Level 3, Liabilities							0
Transfers out of Level 3, Liabilities							$ 0
Customer Concentration Risk | Total Revenue
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Number of customers | customer							2	1
Customer Concentration Risk | Total Revenue | One customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Concentration risk percentage	71.00%			64.00%			71.00%
Customer Concentration Risk | Total Revenue | Two customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Concentration risk percentage	81.00%						81.00%	55.00%
Customer Concentration Risk | Accounts Receivable
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Number of customers | customer							2		2
Customer Concentration Risk | Accounts Receivable | Two customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Concentration risk percentage							86.00%		89.00%
Customer Concentration Risk | COVID-19 testing contract | One customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Concentration risk percentage							53.00%
Customer Concentration Risk | COVID-19 testing contract | Two customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES
Concentration risk percentage							69.00%